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Introduction.
Dry eye syndrome is one of the most common clinical en-
tities encountered by eye care professionals, especially 
among middle-aged and older adults. Dry eye syndrome, 
also known as keratoconjunctivitissicca, or more recently 
dysfunctional tear syndrome, has been defined in various 
ways as the understanding of the disease process evolved. 
Dry eye syndrome is due to disturbances of the lacrimal 
functional unit, which comprises of lacrimal glands, ocu-
lar surface (cornea and conjunctiva), eyelids, meibomian 
glands, and associated sensory and motor nervescausing 
alterations in the volume, composition, distribution or clea-
rance of the tear film.1
Menopause is defined as a phase during which there is 
complete menstrual cessation for at least one year with 
elevated Follicular Stimulating Hormone (FSH) serum levels 
(>40 IU/L).2 The hormonal changes may lead to decrea-
sed tear production which is the root of dry eye syndro-
me. About 60% of menopausal women are affected by dry 
eyes.3 The symptoms of dry eye, namely dryness, itchiness, 
photophobia, blurring of vision, foreign body sensation and 
tearing may cause considerable discomfort to patients and 
subsequently interfere with their quality of lifeUntreated 
dry eye syndrome increase the susceptibility of the eyes 
towards infection as well as causing serious visual impair-
ment.1 HRT has been well accepted to improve the quality 
of life among the postmenopausal women.4
Dry eye syndrome is diagnosed by multiple methods such 
as non-invasive tear break up time, Schirmer’s test and 
fluorescein clearance test.5 Schirmer’s Test (©Haag-Streit 
UK) remains the most popular and practical method in 
many clinical settings as it was also reported to correlate 
well with the basal tear turnover and tear flow.6 It is also 
convenient and cost-effective. At a cut off value of 5 mm, 
the sensitivity and specificity were reported to be 80% and 
53%, respectively.7
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Table 1. Demographic Data.
This study aimed to determine the association between HRT 
and tear production in postmenopausal women and to ob-
serve whether duration of menopause and HRT usage had 
any effect on the tear quantity.
Methods.
This cross-sectional study was performed on postmenopau-
sal women, in the department of Obstetrics and Gynecology 
(O&G), Surgery, Orthopedic and Otorhinolaryngology clinics 
in UKMMC (Universiti Kebangsaan Malaysia Medical Centre). 
The subjects comprised of 3 major ethnic races in Malaysia 
i.e. Malay, Chinese and Indian. These subjects were either 
with or without HRT. The sample size was calculated from 
Sample Size Calculations in Clinical Research. A total of 140 
patients who were with or without HRT were assessed over 
a period of 3 months. Prior ethical approval was obtained 
from the ethics and research committee of the Faculty of 
Medicine, Universiti Kebangsaan Malaysia (FF-017-2009). 
The inclusion criteria were postmenopausal women diagno-
sed within the last 10 years, with or withoutHRT. Patients 
with systemic disorders known to cause dry eyes such as 
Rheumatoid Arthritis, Diabetes Mellitus, Thyroid Disease, 
AIDS, Graft Versus Host Disease, Parkinson’s Disease, pa-
tients who had underwent bone marrow transplant, pa-
tients on medications known to cause dry eyes like an-
ticholinergic medications, Non-steroidal Anti Inflammatory 
Drugs, Beta-blocker and radiation therapy, patients with 
known ocular surface diseases like Herpes Simplex Keratitis 
and Herpes Zoster Ophthalmicus, topical eye drop users 
and patients who had recent ocular surgery within 3 mon-
ths and contact lens wearer were excluded. 
Following a written informed consent, a brief ocular and 
medical history was obtained followed by a brief external 
eye examination. Schirmer’s Test was then performed by 
trained medical students. Following 5 minutes of topical 
anesthesia application with Proparacaine Hydrochloride 
0.5%, A Schirmer’s strip was placed at the inferior conjuncti-
val fornix by placing the bent round wick end of the test 
strip at the temporal one–third of the lower eyelid margin to 
avoid corneal touch. The strip was left for 5 minutes while 
permitting normal blinking or eye closure. The length of 
the moistened area of the strip was then measured using 
a millimeter scale. A reading of less than 5 mm was consi-
dered to be dry. 
A total of 140 patients with 70 patients in each arm of pa-
tients with and without HRT were recruited to make the 
power of study to be 95%. Data was analyzed using the Sta-
tistical Package for Social Science (SPSS) standard version 
13.0. T test, chi square and Pearson correlation test was 
used for data analysis. A value of p<0.05 was considered 
significant.
Results.
A total of 140 patients were recruited. There was equal 
number of participants in both groups of patients with or 
without HRT. Age ranged from 46 to 74 years old. The mean 
age was 57.89±11.89 years old. The Malays (57.9%) formed 
slightly more than half of the study population followed by 
Chinese (34.3%), Indian (6.4%) and others (1.4%, Table 1). 
Among the HRT users, almost three quarter (74.3%) of the 
patients do not have dry eyes as compared to the non HRT 
users in which 50% were found to have dry eyes. This di-
fference was found to be statistically significant (p = 0.003) 
(Table 1, Figure 1).
Among those without HRT, there was no significant asso-
ciation between the occurrence of dry eyes and the du-
ration of menopause. (r=-0.174, p=0.15). For those on HRT 
treatment, Pearson correlation test also showed no signi-
ficant association between the tear quantity and duration 
of HRT consumption (r value = -0.133 and p=0.271, Figure 
2 and 3).
Discussion.
The role of HRT inhelping tear production is not well unders-
tood. Many clinical studies agreed that administration of 
Dry eye Non Dry eye Total p value 
Age (years)
    Mean (SD) 57.89 ± 11.89
Race, n (%) 0.870
    Malay 81 (57.9)
    Chinese 48 (34.3)
    Indian 9 (6.4)
    Others 2 (1.4)
HRT, n (%) 0.003
    HRT Users 18 (25.7) 52 (74.3) 70 (50)
    Non HRT users 35 (50.0) 35 (50.0) 70 (50)
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estrogen increases both the quantity and quality of tears.8,9 
Improvement in tear break-up time (TBUT) and Schirmer’s 
test was also reported after the constitution of hormonal 
therapy.10 Lacrimal secretion increases with the usage of 
combination of estrogen and progesterone treatment.11 We 
includedpatients on all types of HRT whether estrogen alo-
ne or combined with progesterone.
Despite many supporting clinical researches on the benefit 
of HRT on dry eyes symptoms, there was also contradicting 
data suggesting estrogen as an exacerbating factor for dry 
eyes.12,13 The contradictory results may be attributed to the 
different tools used to define dry eyes.
Dry eye syndrome is common in the older population.14 But 
it remains difficult to diagnose because of the lack of a 
gold standard diagnostic testand it is complex etiology and 
pathophysiology.15 Measurement of tear osmolarity might 
provide a “gold standard” of diagnosis, but a practical tear 
osmolarity test is not available, to date.16
As in the present study, Schirmer’s strip is still the most 
clinically reliable method in managing dry eyes cases.5,6 The 
Schirmer test is widely used clinically for assessing tear 
production.17,18
Although there are many small studies which fail toprove 
the beneficial effect of HRT for dry eyes, the association of 
menopause and increasing symptoms of dry eyes has been 
well elaborated.13,19 We found higher incidence of dry eyes 
in menopausal women without HRT treatment as compared 
to those on hormonal therapy. Even though the duration 
of treatment was not found to be an important factor in 
our clinical setting, having HRT on board does help to eli-
minate dry eyes among post menopausal women in our 
population.
Argument exists on the fact that the duration of menopause 
increases dry eyes syndrome.20 This does not seem to be 
true in our population as the duration of menopausedoes 
not increase the incidence of dry eyes among non HRT user. 
The findings in the present study support the ocular impor-
tance of HRT in elderly women.
Apart from continuous prescription of ophthalmic lubrica-
tion, reassurance and discussion on the disease may help 
to alleviate anxiety and offer additional information for our 
patients. This cross sectional study however may not be 
able to elaborate further on the correlation of symptoms 
and severity of the disease. 
Further analytic study in the same setting would be able 
to evaluate thoroughly the significance of dry eyes in this 
group of patient. Apart from hormonal factor, considera-
tion of other confounding factors such as surrounding envi-
ronment and individual social activity would certainly give 
more useful information as to the effect of prolong HRT 
consumption or duration of menopause on dry eyes.
In conclusion, HRT use is associated with improved tear 
production in  postmenopausal women. However, the du-
ration of HRT consumption is not associated with improved 
dry eye condition. Schirmer’s test is still a useful clinical 
method to supplement other diagnostic criteria such as tear 
break-up time (TBUT) and symptoms-based questionnaire, 
to further confirm the diagnosis of dry eye.
Figure 1. Comparison of the occurrence of dry eyes between HRT users and 
non HRT users. There was significant difference between these two groups. 
HRT users showed significant reduction in the number of patients with dry 
eyes. (p=0.003)
Figure 2. Relationship between duration of menopause in non HRT users 
with dry eyes. There was no significant association between the occurrence 
of dry eyes and the duration of menopause. (Pearson correlation test; 
r=0.174, p=0.15).
Figure 2. Relationship between duration of HRT consumption and dry eyes. 
There was no significant association between the occurrence of dry eyes 
and duration of HRT consumption. (r value = -0.133 and p=0.271).
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